Scarica l'app Stockscreener
14.82
1.30%
0.19
Precedente Chiudi:
$14.63
Aprire:
$14.65
Volume 24 ore:
1.80M
Relative Volume:
0.77
Capitalizzazione di mercato:
$4.66B
Reddito:
$2.68B
Utile/perdita netta:
$-184.45M
Rapporto P/E:
-21.78
EPS:
-0.6805
Flusso di cassa netto:
$229.23M
1 W Prestazione:
+2.07%
1M Prestazione:
+14.26%
6M Prestazione:
+57.66%
1 anno Prestazione:
+87.36%
Intervallo 1D:
$14.57
$14.99
Intervallo di 1 settimana:
$14.32
$14.99
Portata 52W:
$6.685
$15.00
Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile
Nome
Amneal Pharmaceuticals Inc
Settore
Telefono
908-947-3120
Indirizzo
400 Crossing Boulevard, 3rd Floor, Bridgewater
Compare AMRX vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMRX
Amneal Pharmaceuticals Inc
|
14.82 | 4.60B | 2.68B | -184.45M | 229.23M | -0.6805 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.46 | 58.03B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
126.65 | 55.37B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.20 | 49.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.98 | 39.50B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
473.66 | 20.50B | 3.13B | 1.27B | 1.12B | 26.39 |
Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-06-06 | Iniziato | Goldman | Buy |
| 2025-02-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-06 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Sector Perform |
| 2021-03-08 | Aggiornamento | Goldman | Sell → Buy |
| 2020-12-14 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-12-14 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-07-27 | Iniziato | Goldman | Sell |
| 2020-05-12 | Aggiornamento | Guggenheim | Sell → Neutral |
| 2019-12-12 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | Downgrade | JP Morgan | Neutral → Underweight |
| 2019-11-07 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-07-22 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-07-11 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-07-08 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2019-06-11 | Iniziato | Barclays | Equal Weight |
| 2019-05-21 | Aggiornamento | Raymond James | Mkt Perform → Strong Buy |
| 2019-03-20 | Iniziato | SunTrust | Buy |
| 2019-03-08 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2018-12-14 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-16 | Downgrade | SunTrust | Buy → Hold |
| 2018-08-13 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-07-23 | Iniziato | Morgan Stanley | Overweight |
| 2018-06-22 | Iniziato | B. Riley FBR, Inc. | Buy |
Mostra tutto
Amneal Pharmaceuticals Inc Borsa (AMRX) Ultime notizie
Resistance Check: How does Amneal Pharmaceuticals Inc perform in inflationary periodsPortfolio Value Summary & Smart Money Movement Tracker - baoquankhu1.vn
Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market - Benzinga
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Up 87.3% in January - MarketBeat
What Amneal Pharmaceuticals (AMRX)'s Addition to the S&P 1000 Index Means For Shareholders - Yahoo Finance
Options Flow: Can Amneal Pharmaceuticals Inc continue delivering strong returns2025 Technical Patterns & Fast Exit and Entry Strategy Plans - baoquankhu1.vn
Is Amneal Pharmaceuticals Inc. in a long term uptrend2025 Momentum Check & Long-Term Growth Portfolio Plans - mfd.ru
What Amneal Pharmaceuticals (AMRX)'s Index Additions and Opioid Settlement Mean For Shareholders - simplywall.st
Earnings Report: Will Amneal Pharmaceuticals Inc benefit from current market trendsWeekly Risk Report & Verified Momentum Watchlists - baoquankhu1.vn
What are the future prospects of Amneal Pharmaceuticals IncJuly 2025 News Drivers & Fast Gain Stock Tips - baoquankhu1.vn
Amneal Receives FDA Approval for Sodium Oxybate Oral Solution - Sleep Review
Breakouts Watch: What’s the outlook for SPAR Group Inc.’s sectorTrade Analysis Summary & High Win Rate Trade Alerts - baoquankhu1.vn
Is Amneal Pharmaceuticals (AMRX) a Great Value Stock Right Now? - Yahoo Finance
Guidance Update: Is Amneal Pharmaceuticals Inc a strong candidate for buy and holdTrade Analysis Summary & Low Risk Entry Point Guides - baoquankhu1.vn
Amneal Pharmaceuticals Refinances Term Loans, Lowers Interest Costs - TipRanks
Amneal Pharma Says On Feb 2nd, Co Enters Amendment No. 2 To Term Loan Credit AgreementSEC Filing - TradingView
Amneal Pharmaceuticals Signs Term Loan Credit Agreement Amendment With JPMorgan Chase - TradingView
How Investors Are Reacting To Amneal Pharmaceuticals (AMRX) Index Additions And Opioid Settlement Resolution - Sahm
Will Amneal (AMRX) beat estimates again in its next earnings report? - MSN
Amneal initiates nationwide settlement for opioid-related claims - MSN
Aug Sentiment: Is Amneal Pharmaceuticals Inc stock a hidden gem2025 Pullback Review & Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Risk Check: Does Ormat Technologies Inc stock benefit from AI growth2025 Market Outlook & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
AustralianSuper Pty Ltd Makes New Investment in Amneal Pharmaceuticals, Inc. $AMRX - MarketBeat
Is It Too Late To Consider Amneal Pharmaceuticals (AMRX) After Its Strong Multi‑Year Share Price Run? - Yahoo Finance
Opioid Settlement And Index Inclusion Reframe Amneal Pharmaceuticals Risk And Reach - Yahoo Finance
Published on: 2026-01-30 06:37:48 - baoquankhu1.vn
Amneal initiates nationwide opioid settlement (AMRX:NASDAQ) - Seeking Alpha
Is It Too Late To Consider Amneal Pharmaceuticals (AMRX) After Its Strong Multi Year Run? - Sahm
Amneal Finalizes Nationwide Opioid Settlement Implementation Plan - TipRanks
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index - The Manila Times
Amneal Pharma To Settle Majority Of Opioids-Related Claims - TradingView
Amneal Pharmaceuticals Finalizes Nationwide Opioids Settlement - TradingView
Amneal Pharmaceuticals, Inc. Added to S&P SmallCap 600® Index - Quiver Quantitative
Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report? - sharewise.com
Amneal Pharmaceuticals (NASDAQ:AMRX) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Amneal Pharmaceuticals, Inc. $AMRX Shares Sold by SG Americas Securities LLC - MarketBeat
TTM Technologies, Dutch Bros to join S&P 400 Index; Amneal, Apellis to be part of S&P SmallCap 600 (CIVI:NYSE) - Seeking Alpha
Amneal, LegalZoom, others rise as S&P Dow Jones Indices announces index changes - Investing.com Canada
Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 1-Year HighStill a Buy? - MarketBeat
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026 - The Manila Times
Can Amneal Pharmaceuticals Inc. be the next market leaderWeekly Stock Report & Safe Entry Momentum Tips - mfd.ru
Risk Recap: Can Amneal Pharmaceuticals Inc. be the next market leaderNew Guidance & High Accuracy Swing Entry Alerts - baoquankhu1.vn
2 Reasons to Sell AMRX and 1 Stock to Buy Instead - Finviz
Can Amneal Pharmaceuticals Inc. continue delivering strong returnsJuly 2025 Volume & AI Enhanced Trading Alerts - mfd.ru
Stock Recap: Is ACAD in a bullish channelJuly 2025 Short Interest & Smart Allocation Stock Reports - baoquankhu1.vn
Has Amneal Pharmaceuticals (AMRX) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Assessing Amneal Pharmaceuticals (AMRX) Valuation After Recent Share Price Momentum - Sahm
Truist raises PT on Amneal Pharmaceuticals (AMRX) to $15 from $14 - MSN
Profit Recap: Is Amneal Pharmaceuticals Inc in a long term uptrend2025 Geopolitical Influence & Advanced Technical Signal Analysis - baoquankhu1.vn
Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 12-Month HighHere's Why - MarketBeat
Amneal Pharmaceuticals stock hits 52-week high at $13.48 - Investing.com
Amneal Pharmaceuticals Inc Azioni (AMRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.19%
0.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):